Articles related to TYPE 2 DIABETES

Explore the study’s analysis, which also uncovers potential cardiovascular benefits associated with SGLT2i initiation among patients with gout and type 2 diabetes.

Brenzavvy, the latest addition to the diabetes treatment landscape, promises a cost-effective approach to managing type 2 diabetes. Discover how this newly approved drug could redefine the treatment paradigm for patients.

Orforglipron is a novel once-daily oral GLP-1 receptor agonist that has been shown to be effective in reducing weight in adults with obesity or overweight. Further studies are needed to establish whether the health benefits seen with injectable GLP-1 receptor agonists are shared by orforglipron.

Dexcom’s innovative continuous glucose monitor is set to transform the management of type 2 diabetes for non-insulin users in the US, offering personalized insights to help them optimize their lifestyle choices while minimizing the need for insulin.

Explore the benefits of time-restricted eating, a diet pattern that suggests fewer, regular meals and fasting periods could improve insulin resistance, brain health, and glycemic control, potentially reducing the risk of developing type 2 diabetes and obesity.

Explore how metformin, a widely accessible diabetes drug, might play a critical role in preventing long COVID when given during the acute phase of COVID-19.